NDC 73380-4700

LUMOXITI

Moxetumomab Pasudotox

LUMOXITI is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Innate Pharma, Inc.. The primary component is Moxetumomab Pasudotox.

• Product ID: 73380-4700_50a54d82-8f62-4e80-a35f-cd51a48bb0e5
• NDC: 73380-4700
• Product Type: Human Prescription Drug
• Proprietary Name: LUMOXITI
• Generic Name: Moxetumomab Pasudotox
• Dosage Form: Injection, Powder, Lyophilized, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-05-15
• Marketing Category: BLA / BLA
• Application Number: BLA761104
• Labeler Name: Innate Pharma, Inc.
• Substance Name: MOXETUMOMAB PASUDOTOX
• Active Ingredient Strength: 1 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 73380-4700-1

1 VIAL in 1 CARTON (73380-4700-1) > 1 mL in 1 VIAL

• Marketing Start Date: 2020-05-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 73380-4700-1 [73380470001]

LUMOXITI INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

• Marketing Category: BLA
• Application Number: BLA761104
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-05-15

Drug Details

NDC Crossover Matching brand name "LUMOXITI" or generic name "Moxetumomab Pasudotox"

NDC	Brand Name	Generic Name
0310-4700	LUMOXITI	moxetumomab pasudotox
73380-4700	LUMOXITI	MOXETUMOMAB PASUDOTOX